Warren L. Denning

3.0k total citations · 1 hit paper
16 papers, 666 citations indexed

About

Warren L. Denning is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Warren L. Denning has authored 16 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Warren L. Denning's work include Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Warren L. Denning is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). Warren L. Denning collaborates with scholars based in United States, Czechia and Ukraine. Warren L. Denning's co-authors include John V. Heymach, Ignacio I. Wistuba, Vassiliki A. Papadimitrakopoulou, Lauren A. Byers, Yanyan Lou, Jing Wang, Don L. Gibbons, Lixia Diao, You Hong Fan and Jaime Canales Rodriguez and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

In The Last Decade

Warren L. Denning

16 papers receiving 662 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma

2016 349 citations Yanyan Lou, Lixia Diao et al. Clinical Cancer Research profile →

Peers

Countries citing papers authored by Warren L. Denning

Since Specialization

Citations

This map shows the geographic impact of Warren L. Denning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Warren L. Denning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Warren L. Denning more than expected).

Fields of papers citing papers by Warren L. Denning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Warren L. Denning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Warren L. Denning. The network helps show where Warren L. Denning may publish in the future.

Co-authorship network of co-authors of Warren L. Denning

This figure shows the co-authorship network connecting the top 25 collaborators of Warren L. Denning. A scholar is included among the top collaborators of Warren L. Denning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Warren L. Denning. Warren L. Denning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Antitumor activity of CD56-chimeric antigen receptor T cells in neuroblastoma and SCLC models 2018 ·Oncogene ·(unknown), Warren L. Denning, Sonny Ang, Simon Olivares, Tiejuan Mi, Kirsten C. Switzer, Harjeet Singh, Helen Huls, (unknown), Bonnie S. Glisson, Laurence J.N. Cooper, John V. Heymach	45
2	P2.03a-048 The CDK4/6 Inhibitor G1T28 Protects Immune Cells from Cisplatin-Induced Toxicity in vivo and Inhibits SCLC Tumor Growth 2017 ·Journal of Thoracic Oncology ·Irene Guijarro, Alissa Poteete, Renata Ferrarotto, Warren L. Denning, Haïfa Hamdi, Patrick J. Roberts, Rajesh Malik, John Bisi, Jessica A. Sorrentino, Jay C. Strum, Emily Roarty, John V. Heymach	1
3	Dysregulation of Systemic and Mucosal Humoral Responses to Microbial and Food Antigens as a Factor Contributing to Microbial Translocation and Chronic Inflammation in HIV-1 Infection 2017 ·PLoS Pathogens ·Zdeněk Hel, Jun Xu, Warren L. Denning, E. Scott Helton, Richard P. H. Huijbregts, Sonya L. Heath, Edgar T. Overton, Benjamin S. Christmann, Charles O. Elson, Paul A. Goepfert, Jiří Městecký	19
4	STK11/LKB1 co-mutations to predict for de novo resistance to PD-1/PD-L1 axis blockade in KRAS-mutant lung adenocarcinoma. 2017 ·Journal of Clinical Oncology ·Ferdinandos Skoulidis, Matthew D. Hellmann, Mark M. Awad, Hira Rizvi, Brett W. Carter, Warren L. Denning, Yasir Y. Elamin, Jianjun Zhang, Giulia C. Leonardi, Darragh Halpenny, Andrew J. Plodkowski, Niamh M. Long, Jeremy J. Erasmus, Vassiliki A. Papadimitrakopoulou, Kwok‐Kin Wong, Ignacio I. Wistuba, Pasi A. Jänne, Charles M. Rudin, John V. Heymach	22
5	Epithelial–Mesenchymal Transition Is Associated with a Distinct Tumor Microenvironment Including Elevation of Inflammatory Signals and Multiple Immune Checkpoints in Lung Adenocarcinoma breakdown → 2016 ·Clinical Cancer Research ·Yanyan Lou, Lixia Diao, Edwin R. Parra, Warren L. Denning, Limo Chen, You Hong Fan, Lauren A. Byers, Jing Wang, Vassiliki A. Papadimitrakopoulou, Carmen Behrens, Jaime Canales Rodriguez, Patrick Hwu, Ignacio I. Wistuba, John V. Heymach, Don L. Gibbons	349
6	The CDK4/6 inhibitor G1T28 to protect immune cells and fibroblasts from chemotherapy and radiation-induced toxicity in vitro and to maintain efficacy of chemotherapy in SCLC Rb-deficient cells. 2016 ·Journal of Clinical Oncology ·Irene Guijarro, Warren L. Denning, Renata Ferrarotto, Alissa Poteete, Uma Giri, John Bisi, Jessica A. Sorrentino, Patrick J. Roberts, Jay C. Strum, Rajesh Malik, Emily Roarty, John V. Heymach	1
7	Association of inactivation of STK11/ LKB1 with a suppressive immune microenvironment in lung adenocarcinoma (LUAC). 2015 ·Journal of Clinical Oncology ·Ferdinandos Skoulidis, Warren L. Denning, Lixia Diao, Pan Tong, You Hong Fan, Vassiliki A. Papadimitrakopoulou, Julie Izzo, Carmen Behrens, Humam Kadara, Edwin R. Parra, Jaime Rodriguez‐Canales, Jing Wang, Don L. Gibbons, Lauren A. Byers, Ignacio I. Wistuba, John V. Heymach	2
8	Association of epithelial-mesenchymal transition status with PD1/PDL1 expression and a distinct immunophenotype in non-small cell lung cancer: Implications for immunotherapy biomarkers. 2014 ·Journal of Clinical Oncology ·Yanyan Lou, Lixia Diao, Lauren A. Byers, Don L. Gibbons, Warren L. Denning, Jing Wang, Vassiliki A. Papadimitrakopoulou, Ignacio I. Wistuba, Sangeeta Goswami, María Angélica Cortez, James W. Welsh, Jonathan M. Kurie, John V. Heymach	11
9	Metastasis Suppressor KISS1 Seems to Reverse the Warburg Effect by Enhancing Mitochondrial Biogenesis 2013 ·Cancer Research ·Wen Liu, Benjamin H. Beck, Kedar S. Vaidya, Kevin T. Nash, (unknown), Scott W. Ballinger, (unknown), Warren L. Denning, Anne R. Diers, Aimee Landar, Animesh Dhar, Tomoo Iwakuma, Danny R. Welch	69
10	Metastasis suppressors in breast cancers: mechanistic insights and clinical potential 2013 ·Journal of Molecular Medicine ·(unknown), Sitaram Harihar, Warren L. Denning, Rahul K. Sharma, Danny R. Welch	47
11	Optimization of the Transductional Efficiency of Lentiviral Vectors: Effect of Sera and Polycations 2012 ·Molecular Biotechnology ·Warren L. Denning, Suvendu Das, (unknown), Jun Xu, John C. Kappes, Zdeněk Hel	51
12	Limited Transplantation of Antigen-Expressing Hematopoietic Stem Cells Induces Long-Lasting Cytotoxic T Cell Responses 2011 ·PLoS ONE ·Warren L. Denning, Jun Xu, (unknown), Christopher A. Klug, Zdeněk Hel	1
13	Induction of protective cytotoxic T-cell responses by a B-cell-based cellular vaccine requires stable expression of antigen 2009 ·Gene Therapy ·(unknown), Jun Xu, Warren L. Denning, Zdeněk Hel	19
14	A model for testing the immunogenicity of simian immunodeficiency virus and simian–human immunodeficiency virus vaccine candidates in mice 2009 ·Journal of Virological Methods ·Jun Xu, Matthew Kelly, Warren L. Denning, Zdeněk Hel	1
15	CD4 T Cell-Induced, Bid-Dependent Apoptosis of Cutaneous Dendritic Cells Regulates T Cell Expansion and Immune Responses 2006 ·The Journal of Immunology ·(unknown), (unknown), Warren L. Denning, (unknown), Craig A. Elmets, Laura Timares	9
16	Relationships Between Vegetative and Life History Traits and Fitness in a Novel Field Environment: Impacts of Herbivores 2005 ·Evolutionary Ecology ·Courtney J. Murren, Warren L. Denning, Massimo Pigliucci	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact